A Study to Evaluate the Pharmacokinetics of BMS-986141 in Participants With Hepatic Impairment Compared to Healthy Participants
NCT02985632
·
clinicaltrials.gov ↗
PHASE1
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class
Stopped
Business objectives have changed.
Conditions
Hepatic Impairment
Interventions
DRUG:
BMS-986141
Sponsor
Bristol-Myers Squibb